All Stories

  1. Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study
  2. Kurzfristige Lebensqualitätsbewertung nach Nasennebenhöhlenoperation bei chronischer Rhinosinusitis
  3. Long-Term Perspectives on Chronic Rhinosinusitis with Nasal Polyps: Evaluating Recurrence Rates after Functional Endoscopic Sinus Surgery in the Biologics Era—A 5-Year Follow-Up Study
  4. Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)
  5. Perceptual, aerodynamic and acoustic outcomes of surgical technique for sulcus vocalis patients: A systematic review and meta analysis
  6. Normative data for interpreting the SNOT-22
  7. The Impact of Antibiotics and Steroids on the Nasal Microbiome in Patients with Chronic Rhinosinusitis: A Systematic Review According to PICO Criteria
  8. Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice
  9. High-Definition 3D Exoscope in Pediatric Otorhinolaryngology: A Systematic Literature Review
  10. Impatto della pandemia COVID-19 sull’otorinolaringoiatria pediatrica
  11. Raccomandazioni pratiche nella gestione ambulatoriale della rinosinusite cronica con poliposi nasale severa, nell’era dei biologici
  12. Diagnostic therapeutic assistance pathway (PDTA) of type 2 chronic rhinosinusitis
  13. Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
  14. Normative values of the topological metrics of the structural connectome: A multi-site reproducibility study across the Italian Neuroscience network
  15. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)
  16. Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts
  17. Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?
  18. La gestione del paziente con rinosinusite cronica e poliposi nasale in Italia: expert opinion sul percorso diagnostico-terapeutico
  19. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
  20. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
  21. Targeting Neuroinflammation to Alleviate Chronic Olfactory Dysfunction in Long COVID: A Role for Investigating Disease-Modifying Therapy (DMT)?
  22. Does a closed reduction improve aesthetical and functional outcome after nasal fracture?
  23. Systematic Review of Parotid Gland Sarcomas: Multi-Variate Analysis of Clinicopathologic Findings, Therapeutic Approaches and Oncological Outcomes That Affect Survival Rate
  24. Effects of the Silica Dust on the Nasal Mucosa of Ceramic Workers
  25. Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.
  26. The Role of Allergen-Specific Immunotherapy in ENT Diseases: A Systematic Review
  27. Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics
  28. Long-term outcomes and quality of life following parotidectomy for benign disease
  29. Survey on Use of Local and Systemic Corticosteroids in the Management of Chronic Rhinosinusitis with Nasal Polyps: Identification of Unmet Clinical Needs
  30. The Present and Future of Allergen Immunotherapy in Personalized Medicine
  31. Quantitative MRI Harmonization to Maximize Clinical Impact: The RIN–Neuroimaging Network
  32. Advances in chronic rhinosinusitis in 2020 and 2021
  33. Long-Term Subjective and Objective Assessment of Smell and Taste in COVID-19
  34. Correlation between olfactory function, age, sex, and cognitive reserve index in the Italian population
  35. Sensitization to Gibberellin-Regulated Protein (Peamaclein) Among Italian Cypress Pollen–Sensitized Patients
  36. Ceramic Workers and the Inflammatory Effects of the Silica Dust on the Nasal Mucosa Detected by Nasal Cytology: a Pilot Study
  37. Perioperative Management of Patients Affected by Ischemic Cardiomyopathy
  38. Allergen Immunotherapy management during vaccinations: An international survey
  39. Bilateral and Ipsilateral Central Neck Dissection in Total Thyroidectomy: a Long Term Comparison of Complications
  40. Nasal cytology identifies allergic rhinitis phenotypes for managing allergen immunotherapy in clinical practice
  41. Diagnostic performance of nasal cytology
  42. How to predict the outcome of septorhinoplasty? A normative study of ROE and FROI-17 scores
  43. Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis
  44. The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
  45. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management
  46. Long-term omalizumab efficacy in allergic rhinitis
  47. Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis
  48. Mepolizumab Effectiveness and Allergic Status in Real Life
  49. Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction
  50. Diagnosis of Obstructive Sleep Apnea in Patients with Allergic and Non-Allergic Rhinitis
  51. The role of allergoids in allergen immunotherapy: from injective to sublingual route
  52. Eosinophilic lingual tonsillitis induced by sublingual immunotherapy: A case series
  53. Effects of paraprobiotic MIMLh5 in the treatment of chronic rhinopharyngitis
  54. Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications
  55. Biologics for chronic rhinosinusitis with nasal polyps
  56. Total Versus Completion Thyroidectomy: A Multidimensional Evaluation of Long-Term Vocal Alterations
  57. The spectrum of therapeutic activity of mepolizumab
  58. Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes
  59. Size and shape of the inferior vena cava before and after a fluid challenge: a pilot study
  60. Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps
  61. Changes of NGF pathway in allergic rhinoconjunctivitis: A conjunctival allergen challenge study
  62. Therapeutic Applications of Capsaicin in Upper Airways
  63. Factors reducing omalizumab response in severe asthma
  64. Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma
  65. Atrial Fibrillation in the Perioperative Period
  66. Relationship Between Autism And Nasal Cytology
  67. A survey on features of allergic rhinitis in children
  68. Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy